Do Remicade, Plaquenil, and Minocycline Cause Nausea and Vomiting?
Yes, all three medications can cause nausea and vomiting, though the frequency and severity vary significantly between them, with infliximab (Remicade) causing these symptoms most commonly, followed by minocycline, while hydroxychloroquine (Plaquenil) causes them infrequently.
Infliximab (Remicade)
Nausea is one of the most frequently reported adverse events with infliximab. According to the FDA drug label, nausea is listed among the most common side effects of Remicade, along with respiratory infections, headache, coughing, and stomach pain 1. Clinical trial data confirms that nausea occurred frequently in infliximab-treated patients 2.
Key Clinical Points:
- Nausea can occur as part of acute infusion reactions (during or shortly after infusion) or as delayed reactions (3-12 days post-infusion) 1, 3
- Acute infusion reactions may include nausea along with fever, chills, chest pain, and shortness of breath 1
- These reactions occurred in approximately 76% of infliximab-treated patients versus 57% of placebo recipients in clinical trials, though most were mild 2
Management Strategy:
- Monitor patients during and up to 2 hours after infusion for acute reactions 1
- Watch for delayed reactions up to 12 days post-infusion 3
- Consider premedication or slowing infusion rate if reactions occur
- Concomitant immunomodulators or corticosteroids may reduce reaction frequency 3
Minocycline
Minocycline causes gastrointestinal disturbances less frequently than doxycycline, but nausea and vomiting can occur, particularly in overdose situations. The FDA label specifically identifies dizziness, nausea, and vomiting as the adverse events most commonly seen in overdose 4.
Key Clinical Points:
- Doxycycline is more frequently associated with gastrointestinal disturbances than minocycline, with higher doses more likely to cause symptoms 5
- When comparing tetracyclines, minocycline has a relatively better GI tolerability profile than doxycycline
- In pediatric tuberculosis treatment contexts, vomiting from medications like ethambutol can compromise drug delivery, though minocycline was not specifically implicated 6
Management Strategy:
- Take with food to minimize GI upset
- If nausea occurs, consider dose reduction or switching to alternative antibiotic
- Monitor for other minocycline-specific adverse effects (tinnitus, dizziness, pigmentation)
Hydroxychloroquine (Plaquenil)
Hydroxychloroquine causes gastrointestinal adverse effects infrequently. Both chloroquine and hydroxychloroquine have "infrequent GI adverse effects (ie, nausea, vomiting, abdominal pain, and diarrhea)" 7.
Key Clinical Points:
- GI symptoms are less common with hydroxychloroquine compared to chloroquine 7
- In pediatric studies, gastrointestinal symptoms were the most often reported side effect, but overall the drug was considered safe 8
- The drug concentrates in the liver, so caution is needed in patients with hepatic disease or taking other hepatotoxic drugs 7
Management Strategy:
- Take with food or milk to reduce GI upset
- If symptoms persist, consider dose adjustment
- Monitor liver function in patients with pre-existing hepatic conditions 7
Comparative Risk Assessment
Ranking by likelihood of causing nausea/vomiting:
- Infliximab (Remicade): Most common - listed as a frequent adverse event
- Minocycline: Moderate - less than doxycycline but can occur
- Hydroxychloroquine (Plaquenil): Least common - infrequent GI effects
Important Caveats
- Drug interactions matter: When these medications are combined with other agents, the risk profile may change
- Individual variability: Some patients may experience significant GI symptoms even with medications that infrequently cause them
- Timing considerations: With infliximab, distinguish between acute infusion reactions and delayed reactions, as management differs 1, 3
- Dose-dependent effects: Higher doses of minocycline and other tetracyclines increase GI symptom likelihood 5